Overall APLS gets a fundamental rating of 5 out of 10. We evaluated APLS against 525 industry peers in the Biotechnology industry. APLS has an average financial health and profitability rating. APLS is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make APLS a good candidate for growth investing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

APLS had positive earnings in the past year.
In the past year APLS had a positive cash flow from operations.
In the past 5 years APLS always reported negative net income.
In the past 5 years APLS always reported negative operating cash flow.

1.2 Ratios

APLS has a better Return On Assets (4.25%) than 90.86% of its industry peers.
APLS's Return On Equity of 11.21% is amongst the best of the industry. APLS outperforms 93.33% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.15%, APLS belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	4.25%
ROE	11.21%
ROIC	8.15%

ROA(3y)-58.39%

ROA(5y)-59.14%

ROE(3y)-247.4%

ROE(5y)-257.29%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

APLS has a Profit Margin of 4.43%. This is amongst the best in the industry. APLS outperforms 89.33% of its industry peers.
APLS has a better Operating Margin (7.91%) than 90.48% of its industry peers.
APLS has a Gross Margin of 88.85%. This is amongst the best in the industry. APLS outperforms 90.86% of its industry peers.
In the last couple of years the Gross Margin of APLS has declined.

		Industry Rank	Sector Rank
OM	7.91%
PM (TTM)	4.43%
GM	88.85%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.7%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

APLS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for APLS has been increased compared to 1 year ago.
APLS has more shares outstanding than it did 5 years ago.
APLS has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.65, we must say that APLS is in the distress zone and has some risk of bankruptcy.
APLS has a Altman-Z score of 0.65. This is in the better half of the industry: APLS outperforms 62.67% of its industry peers.
The Debt to FCF ratio of APLS is 5.78, which is a neutral value as it means it would take APLS, 5.78 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of APLS (5.78) is better than 91.81% of its industry peers.
APLS has a Debt/Equity ratio of 0.90. This is a neutral value indicating APLS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.90, APLS is doing worse than 73.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.9
Debt/FCF	5.78
Altman-Z	0.65

ROIC/WACC0.93

WACC8.76%

2.3 Liquidity

A Current Ratio of 3.54 indicates that APLS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.54, APLS is in line with its industry, outperforming 42.10% of the companies in the same industry.
APLS has a Quick Ratio of 3.10. This indicates that APLS is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 3.10, APLS is not doing good in the industry: 60.38% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	3.54
Quick Ratio	3.1

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

APLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.40%, which is quite impressive.
Looking at the last year, APLS shows a very strong growth in Revenue. The Revenue has grown by 42.11%.
The Revenue has been growing by 127.23% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)116.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%463.04%

Revenue 1Y (TTM)42.11%

Revenue growth 3Y127.23%

Revenue growth 5YN/A

Sales Q2Q%132.98%

3.2 Future

Based on estimates for the next years, APLS will show a very strong growth in Earnings Per Share. The EPS will grow by 26.57% on average per year.
APLS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.75% yearly.

EPS Next Y116.93%

EPS Next 2Y11.09%

EPS Next 3Y25.11%

EPS Next 5Y26.57%

Revenue Next Year28.73%

Revenue Next 2Y6.42%

Revenue Next 3Y10.66%

Revenue Next 5Y13.75%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

APLS is valuated quite expensively with a Price/Earnings ratio of 70.16.
APLS's Price/Earnings ratio is rather cheap when compared to the industry. APLS is cheaper than 90.29% of the companies in the same industry.
APLS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.21.
APLS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	70.16
Fwd PE	N/A

4.2 Price Multiples

APLS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. APLS is cheaper than 92.19% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, APLS is valued cheaply inside the industry as 93.52% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	35
EV/EBITDA	33.61

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as APLS's earnings are expected to grow with 25.11% in the coming years.